How does workers compensation work for CRO and clinical research staff?

A CRO workforce typically spans three class code groups. Clinical research associates (CRAs), clinical monitors, project managers, and data managers classify under clerical office (NCCI 8810) and outside professional/sales codes (NCCI 8742) for staff who travel to sites. Central laboratory, bioanalytical, and specimen-processing staff classify under laboratory codes (analytical and chemical laboratory classifications, broadly comparable to NCCI 4828 chemical laboratory used for biotech research). Biostatistics and regulatory staff classify as clerical.

Because a CRO is largely a professional-services and monitoring operation rather than a manufacturer, the blended workers compensation rate runs low relative to pharma or device manufacturing. The exception is a CRO that operates its own central lab or bioanalytical facility at scale, where the laboratory headcount and exposure shift the blended rate upward.

The distinguishing workers compensation feature of a CRO is travel. CRAs and monitors travel constantly - to investigator sites, between cities, and frequently across the country or internationally. Injuries sustained in the course and scope of work travel are compensable WC claims, and the volume of travel materially raises the practical frequency of claims relative to a sedentary office population.

This puts the CRO at the intersection of workers compensation, commercial auto (hired and non-owned auto for staff renting vehicles), and - for ex-US trials - foreign voluntary workers compensation. Operators that staff trials outside the US should confirm their WC program extends to employees temporarily working abroad, because domestic statutory WC frequently does not respond to foreign incidents without a foreign voluntary endorsement.

A recurring question in CRO program design is which party carries workers compensation for staff at investigator sites. Site coordinators and sub-investigators employed by the research site or institution are covered by that entity's WC program, not the CRO's. The CRO carries WC for its own employees - the monitors and CRAs visiting those sites - and for any staff it directly employs at a central facility.

The clinical trial agreement and the sponsor MSA allocate these responsibilities, and the insurance schedules attached confirm that each party maintains statutory WC for its own personnel. Misalignment here surfaces when a site staffing model uses contractors or shared personnel; the program should track the actual employment relationship.

Sponsor master service agreements and clinical trial agreements near-universally require the CRO to maintain statutory workers compensation plus employers liability (commonly $1M each accident / disease). This is rarely negotiable - it is a baseline procurement requirement, and the certificate of insurance is reviewed at contracting and renewal.

For Texas CROs, the non-subscriber consideration applies as it does for biotech: a Texas employer may technically elect non-subscriber status, but a non-subscriber occupational injury program generally does not satisfy a sponsor MSA statutory WC requirement. Texas CROs in commercial engagement with pharma sponsors generally maintain statutory WC regardless.

A mid-market CRO at $10M revenue with a travel-heavy monitoring workforce and modest central-lab headcount typically pays $20,000-$60,000 annually for WC plus employers liability, with travel and any foreign-trial activity driving the upper end. A CRO operating a substantial central or bioanalytical laboratory shifts higher because of the added laboratory class code exposure.